MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Q&A

Home
Q&A
Facebook Live

Facebook Live: Special Guest Announcement

MStranslate
September 28, 2022
Dr Travis Stiles, Q&A, Research, Videos
On September 25, 2022, our co-founder and chief science communicator, Brett Drummond, took to Facebook Live with a very special guest, Dr Travis Stiles (CEO, Novoron Bioscience). Many who follow MStranslate...
Multiple Sclerosis Cure

Community Q&A: Why Don’t We Have An MS Cure?

MStranslate
October 11, 2021
Community, Opinion, Q&A
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, he shares his opinions on...
COVID-19 vaccines

Community Q&A: COVID-19 Vaccines & MS

MStranslate
September 29, 2021
Community, COVID-19, Q&A, Research
1 Comment
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, it looks at the latest...
blood-brain barrier

Community Q&A: The Blood-Brain Barrier

MStranslate
September 23, 2021
Community, Q&A, Research
2 Comments
What is the blood-brain barrier? Why is the blood-brain barrier important in multiple sclerosis (MS)?  Is research being undertaken to repair the blood-brain barrier in people living with multiple sclerosis,...
MS Virtual 2020

MS Virtual 2020: An In-depth Interview Series

MStranslate
October 29, 2020
Conferences, MS Virtual, Q&A, Research
1 Comment
As our daily coverage of MS Virtual 2020 demonstrated, there we many fascinating presentations delivered across the three days of the conference, covering a vast spectrum of multiple sclerosis research topics...
Facebook Live

Facebook Live: General Research Update – June 2020

MStranslate
June 9, 2020
Community, Q&A, Research
On June 4, 2020, our co-founder and chief science communicator, Brett Drummond, held a Facebook Live event to explain and discuss some of the more recent developments in multiple sclerosis research. Topics...
Travis Stiles

World MS Day: A Video Call with Dr Travis Stiles

MStranslate
June 2, 2020
Community, Dr Travis Stiles, Q&A, Videos
To mark World Multiple Sclerosis Day on May 30, 2020, our co-founder, Brett Drummond, conducted an in-depth video call with friend and Novoron Bioscience CEO, Dr Travis Stiles, in San Diego. Their conversation...
mental health

Strategies for Managing Mental Health: Dr Sally Shaw

MStranslate
May 14, 2020
Community, Dr Sally Shaw, Mental Health, Q&A, Symptoms
2 Comments
On April 29, 2020, we premiered a video on our Facebook page discussing strategies for managing mental health during the coronavirus (COVID-19) pandemic. For this discussion, we were joined by Australian...
COVID-19

Facebook Live: COVID-19 & Multiple Sclerosis

MStranslate
March 23, 2020
Q&A, Videos
On March 20, 2020, we conducted a very important Facebook Live broadcast, discussing what is known about coronavirus (COVID-19) and its implications for people living with multiple sclerosis. The opportunity...
remyelination

Facebook Live: Remyelination – March 2020

MStranslate
March 11, 2020
Q&A, Remyelination, Videos
1 Comment
On March 5, 2020, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss one of the most important topics in multiple sclerosis research,...
  1. 1
  2. 2

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.